oHCM Regional Summit

A new era in treating obstructive hypertrophic cardiomyopathy (oHCM)

3-4 October 2025
Grand Hotel Union Eurostars
Ljubljana, Slovenia

Registration

Meet Our Speakers

Assoc. Prof. Ainars Rudzitis, MD PhD
Pauls Stradins Clinical University Hospital, Riga, Latvia
Biography

Assoc. Prof. Ainars Rudzitis is a prominent cardiologist in Latvia, at the Latvian Centre of Cardiology, Pauls Stradins Clincal University Hospital (Riga, LATVIA). His main field of interest is related to the diagnostics and treatment of pulmonary arterial hypertension, echocardiography, congenital and structural heart disease in adults and rare diseases in cardiology (Fabry disease, amyloidosis, myocarditis).

Ainars Rudzitis is author and co-author of several international publications in echocardiography, congenital heart disease and structural heart disease interventions. His involvement in research currrently is associated with percutaneous transcatheter closure of atrial septal defects, pulmonary hypertension, left atrial appendage closure in patients with atrial fibrillation for stroke prevention, TAVI and rare cardiac diseases.

His expertise in mavacamten dosing and monitoring protocols has advanced oHCM care in the region. As a mentor and collaborator with Baltic cardiology centers, he addresses regional challenges like limited imaging access.

Key Contributions to oHCM
  • Mavacamten Monitoring: Developed echo-guided protocols for mavacamten, ensuring safe titration in Latvia.
  • Regional Solutions: Advocates portable echo devices to address imaging barriers.
  • Education: Trains clinicians in REMS protocols, aligning with ESC/AHA guidelines.
  • Innovation: Promotes AI-enhanced echo analysis for oHCM monitoring.
Contact and Professional Links